Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis

To systematically assess the effect of metformin on colorectal cancer (CRC) risk and mortality in type 2 diabetes mellitus (T2DM) patients. We conducted a systematic search of PubMed, Web of Science, and the Cochrane Library databases for relevant articles before August 2015. Two investigators ident...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xing-kang, Su, Ting-ting, Si, Jian-min, Sun, Lei-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998616/
https://www.ncbi.nlm.nih.gov/pubmed/26886616
http://dx.doi.org/10.1097/MD.0000000000002749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998616/
https://www.ncbi.nlm.nih.gov/pubmed/26886616
http://dx.doi.org/10.1097/MD.0000000000002749

Ejemplares similares